A clinical trial for developing pain scale
- Conditions
- Not Applicable
- Registration Number
- KCT0001808
- Lead Sponsor
- Asan Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 10
Volunteer who consented to participate in the trial
-Any disease that affects autonomic nervous system (diabetes mellitus, catecholamine secreting tumor, depression etc.)
-Any disease that can induce spontaneous pain (rheumatoid arthritis, osteoarthritis, neuropathic pain inducing disease such as herniation of intervertebral disc and spinal stenosis), myopathic pain, or other chronic pain disease
-Blind person or other ophthalmic disease
-Arrhythmia or cardiac disease
-Cerebrovascular disease or prior brain surgery
-Epilepsy or history of psychosis
-Long term administration of sedatives
-Pregnant or possibly pregnant
-Patients who are considered by the investigator to be unsuitable to participate in the study for any other reason not mentioned in the inclusion and exclusion criteria.
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change of pain indicators before and after infusion of remifentanil and normal saline when pain stimulus is not given
- Secondary Outcome Measures
Name Time Method Quantify the response of pain indicators;Adverse events